JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB232855

Crystal violet Assay Kit (Cell viability)

Be the first to review this product! Submit a review

|

(40 Publications)

Crystal Violet Assay Kit ab232855 is used for cytoxicity and cell viability studies with adherent cell cultures.

Individual kit components also available for purchase with a minimum order of 20 units. Contact us to discuss your needs.
2 Images
Microcytotoxicity testing - Crystal violet Assay Kit (Cell viability) (AB232855)
  • Cytotox

Supplier Data

Microcytotoxicity testing - Crystal violet Assay Kit (Cell viability) (AB232855)

Dose-response curve of MCF7 (Human breast adenocarcinoma cell line) cells to Doxorubicin for 72 hours determined by the Crystal violet staining assay. Assays were performed according to the kit protocol in triplicate.

Microcytotoxicity testing - Crystal violet Assay Kit (Cell viability) (AB232855)
  • Cytotox

Supplier Data

Microcytotoxicity testing - Crystal violet Assay Kit (Cell viability) (AB232855)

Dose-response curve of HepG2 (Human liver hepatocellular carcinoma cell line) cells to Doxorubicin for 72 hours determined by the Crystal violet staining assay. Assays were performed according to the kit protocol in triplicate.

Key facts

Detection method

Colorimetric

Sample types

Adherent cells

Assay time

1h

Assay Platform

Microplate reader

Product details

Crystal Violet Assay Kit ab232855 is used for cytoxicity and cell viability studies with adherent cell cultures.

Crystal violet assay principle

The Crystal Violet assay is based on staining cells that are attached to cell culture plates. It relies on the detachment of adherent cells from cell culture plates during cell death. During the assay, dead detached cells are washed away. The remaining attached live cells are stained with Crystal violet. After a wash step, the Crystal violet dye is solubilized and measured by absorbance at 570 nm.

The amount of Crystal Violet staining in the assay is directly proportional to the cell biomass that is attached to the plate. The cell biomass can be used to infer levels of cell viability / cytotoxicity. The Crystal Violet assay assumes that all cells that are attached to the plate are "alive" and that all cells that detach are "dead".

Crystal violet is a triarylmethane dye that binds to ribose type molecules such as DNA in nuclei.

Crystal Violet assay protocol summary:
- remove culture medium
- wash cells
- add Crystal Violet staining solution
- incubate for 20 mins
- wash cells and air dry plate
- add solubilization solution
- analyze using a microplate reader at 570 nm absorbance

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

The Safety Datasheet for this product has been updated for certain countries. Please check the current version in the Support and downloads section.

What's included?

{ "values": { "1000Test": { "sellingSize": "1000 Test", "publicAssetCode":"ab232855-1000Test", "assetComponentDetails": [ { "size":"1 x 115 mL", "name":"10X Wash Buffer I", "number":"AB232855-CMP01", "productcode":"" }, { "size":"1 x 40 mL", "name":"CV Solution", "number":"AB232855-CMP03", "productcode":"" }, { "size":"1 x 100 mL", "name":"CV Solubilization Solution", "number":"AB232855-CMP04", "productcode":"" }, { "size":"1 x 100 µL", "name":"Doxorubicin", "number":"AB232855-CMP02", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Product protocols

Publications (40)

Recent publications for all applications. Explore the full list and refine your search

Biofilm 9:100285 PubMed40496336

2025

Assessing the impact of UV-C exposure on pre-existing cultured marine diatom biofilms.

Applications

Unspecified application

Species

Unspecified reactive species

Kailey N Richard,Andrew Palmer,Geoffrey Swain,Kelli Z Hunsucker

British journal of pharmacology 182:3923-3951 PubMed40344208

2025

A mitochondria-targeting and G-quadruplex structure-binding ligand inducing calcium overload and ferroptosis in human cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Bo-Xin Zheng,Wei Long,Yao-Xun Zeng,Meng-Ting She,Yingying Zheng,Wen-De Zheng,Ya-Kun Wang,Ka-Hin Chan,Alan Siu-Lun Leung,Chun-Ming Chan,Yu-Jing Lu,Wing-Leung Wong

International journal of molecular sciences 26: PubMed40332124

2025

Synergistic HDAC4/8 Inhibition Sensitizes Osteosarcoma to Doxorubicin via pAKT/RUNX2 Pathway Modulation.

Applications

Unspecified application

Species

Unspecified reactive species

Anuja Gajanan Magar,Vivek Kumar Morya,Young-Ho Koh,Kyu-Cheol Noh

Experimental and therapeutic medicine 29:71 PubMed39991715

2025

Proteasome inhibitor MG132 modulates signal transduction pathways in ELT3 uterine leiomyoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Hosouk Joung,So-Ra Yang,Su Bin Lee,Hyunju Liu

International journal of molecular sciences 26: PubMed39859304

2025

MYC Overexpression Enhances Sensitivity to MEK Inhibition in Head and Neck Squamous Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Cuicui Yang,Xiaowu Pang,Shaolei Teng,Shamel Wilson,Xinbin Gu,Guiqin Xie

Scientific reports 14:26038 PubMed39472715

2024

CIGB-300 internalizes and impairs viability of NSCLC cells lacking actionable targets by inhibiting casein kinase-2 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Ying Yi,Lingfeng Dai,Yaqin Lan,Changyuan Tan,Dania M Vázquez-Blomquist,Guirong Zeng,Dejian Jiang,Ke Yang,Silvio E Perea,Yasser Perera

World journal of gastrointestinal oncology 16:3994-4005 PubMed39350979

2024

Senegenin suppresses hepatocellular carcinoma by regulating O-GlcNAcylation.

Applications

Unspecified application

Species

Unspecified reactive species

Xiang Zhang,Li-Qiong Wang,Zhi-Yong Liu

Molecular medicine reports 30: PubMed39301652

2024

Ginkgolic acid regulates myogenic development by influencing the proliferation and differentiation of C2C12 myoblast cells.

Applications

Unspecified application

Species

Unspecified reactive species

Hyunju Liu,Hosouk Joung

Cells 13: PubMed38995006

2024

Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Trang T T Nguyen,Qiuqiang Gao,Jeong-Yeon Mun,Zhe Zhu,Chang Shu,Aaron Naim,Meri Rogava,Benjamin Izar,Mike-Andrew Westhoff,Georg Karpel-Massler,Markus D Siegelin

Oncology reports 52: PubMed38874019

2024

2‑D08 mediates notable anticancer effects through multiple cellular pathways in uterine leiomyosarcoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Hosouk Joung,Hyunju Liu
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com